Jennifer Collins Email

VP Procurement . Poseida Therapeutics

Current Roles

Employees:
314
Revenue:
$46.3M
About
Poseida Therapeutics is translating best-in-class gene engineering technologies into lifesaving cell therapies. The company is developing CAR T-cell immunotherapies for multiple myeloma, prostate and other cancer types, as well as gene therapies for orphan diseases. P-BCMA-101 is Poseida's lead CAR-T therapy currently in Phase 1 clinical development for the treatment of multiple myeloma. Poseida has assembled a suite of industry-leading gene engineering technologies, including the piggyBac DNA Modification System, TAL-CLOVER and Cas-CLOVER site-specific nucleases, and Footprint-Free Gene Editing (FFGE). For more information, visit www.poseida.com.
Poseida Therapeutics Address
9390 Towne Centre Drive
San Diego, CA
United States
Poseida Therapeutics Email

Past Companies

Poseida Therapeutics, Inc.Vice President Procurement
Poseida Therapeutics, Inc.Vice President, Quality Operations
Collins Consulting GroupIndependant Consultant

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.